Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Cash from Investing Activities (2016 - 2025)

Seres Therapeutics (MCRB) has disclosed Cash from Investing Activities for 11 consecutive years, with $181000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 301.11% to $181000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$42000.0 through Dec 2025, down 100.03% year-over-year, with the annual reading at -$42000.0 for FY2025, 100.03% down from the prior year.
  • Cash from Investing Activities hit $181000.0 in Q4 2025 for Seres Therapeutics, up from -$8000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $141.1 million in Q3 2024 to a low of -$20.7 million in Q1 2021.
  • Historically, Cash from Investing Activities has averaged $15.0 million across 5 years, with a median of $2.0 million in 2023.
  • Biggest five-year swings in Cash from Investing Activities: crashed 319.75% in 2021 and later surged 7954.37% in 2024.
  • Year by year, Cash from Investing Activities stood at $13.2 million in 2021, then tumbled by 55.06% to $5.9 million in 2022, then plummeted by 114.8% to -$877000.0 in 2023, then surged by 89.74% to -$90000.0 in 2024, then skyrocketed by 301.11% to $181000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for MCRB at $181000.0 in Q4 2025, -$8000.0 in Q3 2025, and -$181000.0 in Q2 2025.